Page last updated: 2024-10-28

mephentermine and Myocarditis

mephentermine has been researched along with Myocarditis in 1 studies

Mephentermine: A sympathomimetic agent with specificity for alpha-1 adrenergic receptors. It is used to maintain BLOOD PRESSURE in hypotensive states such as following SPINAL ANESTHESIA.

Myocarditis: Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
AGRESS, CM1

Reviews

1 review available for mephentermine and Myocarditis

ArticleYear
THERAPY OF CARDIOGENIC SHOCK.
    Progress in cardiovascular diseases, 1963, Volume: 6

    Topics: Angiotensins; Cardiac Tamponade; Heart Aneurysm; Heart Diseases; Heart Failure; Humans; Hydromorphon

1963